MedPath

A study to see the efficacy of injection vitamin D3 given into the skin warts.

Not Applicable
Conditions
Health Condition 1: B079- Viral wart, unspecified
Registration Number
CTRI/2019/04/018822
Lead Sponsor
Department of Dermatology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. All untreated consecutive patients of verruca vulgaris.

2. Above the age of 14 years.

Exclusion Criteria

1. Pregnant or lactating females.

2. Any evidence of immunosuppression including HIV .

3. With a prior history of hypersensitivity to Vitamin D.

4. History of intake of vitamin D3, anabolic steroids or bisphosphonates in the last 3 months.

5. Patients having any significant systemic illness.

6. Patients having pre procedure serum vitamin D levels >100 ng/ml.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath